For citations:
Besova NS, Titova ТА, Tryakin АА, Artamonova ЕV, Obarevich ЕS, Stroyakovskiy DL, Kalinin ОЕ, Stilidi IS. Ramucirumab with paclitaxel or FOLFIRI as second-line treatment in docetaxel-pre-treated patients with metastatic gastric cancer in real-world setting. Meditsinskiy sovet = Medical Council. 2021;(4S):64-78. (In Russ.) https://doi.org/10.21518/2079-701X-2021-4S-64-78